Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up

Inclusion Criteria

• •A volunteer of any age with a diagnosis of EVD within the past 2 years who is on the Ministry of Health (MOH) Registry of EVD survivors is eligible to participate.
• •Willingness to participate in examinations at one of the participating health facilities
• •Willingness to provide informed consent/assent
• •Individuals on the MOH Registry were PCR positive for EVD and treated at an Ebola Treatment Unit (ETU), Community Care Center (CCC) or holding center. Periodically, participants enrolled will be matched against the MOH Registry to verify that those enrolled are EVD survivors. If a participant enrolled is not on the registry, their antibody levels at baseline will be assessed. If antibody levels are present, the participant will continue to be followed as an EVD survivor. If antibody levels are not present, the participants will no longer be followed as an EVD survivor and may be withdrawn from the study. Participants brought to the NIH Clinical Center will have documentation of positive Ebola virus PCR and a clinical syndrome compatible with acute EVD.
• •EXCLUSION CRITERION FOR EVD SURVIVORS
• •Any condition in the judgment of the study staff that would make the volunteer unable to participate in the study.